
生物类似药显露头角医药研发成本不断攀升——2016年重磅新药研发热点回眸
Biosimilar show a good development prospect, while drug research and development cost is spiralling
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |